Back Login for AI Analysis

    NTLA (STOCKS)

    Intellia Therapeutics, Inc

    $11.930000
    -0.650000 (-5.17%)
    Prev close: $12.580000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Biotechnology
    CEO
    John M. Leonard
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $1,736.83M
    Employees
    598
    P/E (TTM)
    -3.75
    P/B (TTM)
    2.42
    Dividend Yield
    —
    Technical Indicators
    SMA 10
    —
    SMA 20
    —
    SMA 50
    —
    EMA 9
    —
    EMA 21
    —
    RSI
    —
    MACD State
    —

    Analyst Recommendations
    4
    Strong Buy
    10
    Buy
    7
    Hold
    2
    Sell
    Recent News

    No recent news found for this ticker.

    Earnings Surprises
    Period Actual Estimate Surprise Surprise %
    Jun 2026 (Q2)
    $-0.80 $-0.82 +0.0152 +1.86%
    Mar 2026 (Q1)
    $-0.81 $-0.93 +0.1221 +13.10%
    Dec 2025 (Q4)
    $-0.83 $-0.97 +0.1439 +14.78%
    Sep 2025 (Q3)
    $-0.92 $-1.02 +0.1019 +9.97%